GW&K Investment Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13K Hold
92
– – ﹤0.01% 867
2026
Q1
$11K Hold
92
– – ﹤0.01% 863
2025
Q4
$15K Hold
92
– – ﹤0.01% 802
2025
Q3
$12K Hold
92
– – ﹤0.01% 842
2025
Q2
$11K Sell
92
-35
-28% -$4.45K ﹤0.01% 835
2025
Q1
$16K Buy
127
+35
+38% +$5.39K ﹤0.01% 703
2024
Q4
$13K Hold
92
– – ﹤0.01% 719
2024
Q3
$14K Hold
92
– – ﹤0.01% 692
2024
Q2
$12K Hold
92
– – ﹤0.01% 690
2024
Q1
$17K Buy
+92
New +$17.5K ﹤0.01% 559

Other funds holding RGEN

GW&K Investment Management's RGEN Position: Q2 2026 in Review

GW&K Investment Management held its Repligen (RGEN) position steady in Q2 2026 at 92 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #867.

GW&K Investment Management first reported a position in RGEN in Q1 2024 and has held it in 10 quarters since. The position peaked at $17K in Q1 2024. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • GW&K Investment Management held 92 shares of Repligen worth $13K as of Q2 2026.
  • GW&K Investment Management left its Repligen share count unchanged in Q2 2026.
  • Repligen made up ﹤0.01% of GW&K Investment Management's portfolio in Q2 2026, its #867 holding.
  • GW&K Investment Management first reported a position in Repligen in Q1 2024 and has held it in 10 quarters since.
  • GW&K Investment Management's Repligen position peaked at $17K in Q1 2024.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on GW&K Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.